-+ 0.00%
-+ 0.00%
-+ 0.00%

WuXi XDC Selected to Manufacture Akari Therapeutics' AKTX-101 for Phase 1 Clinical Trial

Reuters·12/23/2025 13:30:47

Please log in to view news